H.R.4733 - Opioids and STOP Pain Initiative Act115th Congress (2017-2018)
|Sponsor:||Rep. Welch, Peter [D-VT-At Large] (Introduced 12/21/2017)|
|Committees:||House - Energy and Commerce; Budget; Ways and Means|
|Latest Action:||House - 01/03/2018 Referred to the Subcommittee on Health. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: H.R.4733 — 115th Congress (2017-2018)All Information (Except Text)
Introduced in House (12/21/2017)
Opioids and STOP Pain Initiative Act
This bill establishes and provides funds for the Opioids and STOP Pain Initiative at the National Institutes of Health (NIH) to support pain-related research, including:
- understanding pain, therapies for chronic pain, and alternatives to opioids for pain treatment as directed in the Comprehensive Addiction and Recovery Act of 2016;
- improving options and evidence for medication-assisted treatment and opioid overdose reversal treatments; and
- supporting the Federal Pain Research Strategy.
NIH must establish the Pain Therapy Screening Program to award grants to support the development of new pre-clinical models for pain disorders, and the application of these models in drug, device, or other therapy screening.